To better communicate the problem of antimicrobial resistance (AMR), researchers at The Center For Disease Dynamics, Economics & Policy (CDDEP) developed the Drug Resistance Index (DRI), which provides a snapshot of the effectiveness of antibiotic therapy by country. The DRI resembles stock market indices and combines antibiotic consumption measurements with resistance data to help compare aggregate resistance across time and between countries.
CDDEP researchers also worked to fill the gap in Antibiotic Stewardship Programs in low-and-middle-income countries (LMICs) by developing a checklist feasible to adopt globally in all healthcare facilities. The result was the Checklist for Hospital Antimicrobial Stewardship Programming (CHASP).
Learn more about these and other CDDEP AMR programs and partnerships here.